2016-05-30-世界卫生组织-Diabetes_Malta_2016_country_profile_1页_338kb

Malta Diabetes Profile Summary

Malta has a total population of 419,000 individuals, classified as a high-income country. The mortality rate from diabetes is very low, with fewer than 100 deaths reported in all age groups for both males and females, and similarly for deaths attributable to high blood glucose. Proportions of diabetes-related mortality in total deaths are not available, but non-communicable diseases (NCDs) dominate the cause-of-death statistics, with cardiovascular diseases, other NCDs, and cancers being major contributors.

The age-standardized prevalence of diabetes among males is 11.4%, females is 8.8%, and overall, 10.1%. Key risk factors include high rates of overweight (67.6% overall), obesity (28.7% overall), and physical inactivity (45.2% overall).

In terms of national response, Malta has operational policies and strategies for diabetes, reducing overweight/obesity, and increasing physical activity, along with evidence-based guidelines or standards partly available. A diabetes registry exists and is functional, but recent national risk factor surveys with blood glucose measurement are not available. Medicines like insulin, metformin, and sulphonylurea are basic and generally available in primary care, as are basic technologies such as blood glucose measurement, HbA1c tests, dilated fundus examination, and foot tests, though not all may be fully implemented.

Overall, Malta faces challenges in diabetes management, including low mortality rates, high prevalence of risk factors, and limited availability of evidence-based guidelines.